article thumbnail

Creating intelligence in the pharmaceutical supply chain.

Manufacturing & Logistics IT

Covid-19 is straining supply chains around the world, most notably those of pharmaceutical companies. Control over their supply chain is a major challenge for all pharma companies today. Scarcity of raw materials upstream and overheated demand downstream cause disruptions.

article thumbnail

Environmental Sensors Increase Supply Chain Visibility

Gary Mintchell

Using these sensors, manufacturers, wholesalers, transportation and logistics operators in the food, pharmaceutical and healthcare industries now have cloud-based visibility into a range of environmental factors, including temperature monitoring and moisture detection.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Using Sensors & IoT for Pharmaceutical Manufacturing

ATS

Share Pharmaceutical manufacturing operations are challenging environments for asset maintenance. IoT in pharmaceutical manufacturing supports predictive maintenance strategies that lower costs while raising OEE. is an enabler of customized manufacturing. Referencing the Industry 4.0 Industry 4.0

article thumbnail

Bushu Pharma Recognized with Frost & Sullivan’s 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing and Robust Supply Chain Solutions

Frost & Sullivan Manufacturing

SAN ANTONIO – November 30, 2023 – Frost & Sullivan recently researched the contract development and manufacturing organization industry and, based on its findings, recognizes Bushu Pharma with the 2023 Japan Customer Value Leadership Award.

article thumbnail

Fusion Pharmaceuticals to open radiopharmaceutical manufacturing facility to produce targeted alpha therapies for cancer

Canadian Manufacturing

Photo: Fusion Pharmaceuticals. HAMILTON — Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing radiopharmaceuticals as precision medicines, announced the opening of its radiopharmaceutical manufacturing facility. At full capacity, it is expected to produce over 100,000 doses of TATs per year.

article thumbnail

EU regulation lacks consideration of pharmaceutical industry emissions

E&T

The study has described the current regulation of pharmaceutical companies as being unable to prevent the release of chemicals into the environment throughout the manufacturing supply chain. For veterinary pharmaceuticals, this is possible, but extremely rare.” .

article thumbnail

Fusion Pharmaceuticals to be acquired by AstraZeneca

Canadian Manufacturing

HAMILTON and BOSTON — Fusion Pharmaceuticals Inc., Fusion Pharmaceuticals says that RCs have emerged as a promising modality in cancer treatment over recent years. The acquisition brings manufacturing and supply chain capabilities in actinium-based RCs to AstraZeneca.